CATALYST DOSSIER · UPDATED 2026-11-09
$GRAB
industrials · convergence 0 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $GRAB?
Quantitative
Convergence score : 0 (8 signals firing YoY)
Catalysts
Multi-spoke convergence : 8 convergent signals fired: finra_short, auto_macro_adp_payrolls, auto_macro_banrep_colombia, auto_macro_bls_employment, auto_macro_durable_goods
Risks
Hard-to-borrow / FTD risk : Borrow rate 6.0%, distress score 30
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
HYSR via semis r=+0.83 sympathetic (score 13)
INDI via semis r=+0.83 sympathetic (score 13)
QBTS via tech r=+0.75 sympathetic (score 26)
CIIT via tech r=+0.75 sympathetic (score 24)
AORT via biotech r=+0.63 sympathetic (score 24)
ONCO via biotech r=+0.63 sympathetic (score 20)
Signals Firing
finra_short auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-11-03 sec_top_gappers +8.7% +7.7% ✓ hit 2026-11-03 sec_top_moat_emerging +8.7% +7.7% ✓ hit 2026-10-30 sec_top_gappers +8.3% +5.5% ✓ hit 2026-10-30 sec_top_moat_emerging +8.3% +5.5% ✓ hit 2026-09-15 sec_top_gappers +2.7% -1.4% ✓ hit 2026-09-15 sec_top_moat_emerging +2.7% -1.4% ✓ hit
Lifetime: 6/6 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket HYSR via semis · score 13 INDI via semis · score 13 QBTS via tech · score 26 CIIT via tech · score 24 AORT via biotech · score 24 ONCO via biotech · score 20
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.